Literature DB >> 12740691

Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients.

Wataru Obara1,2, Aritoshi Iida3, Yasushi Suzuki2, Toshihiro Tanaka4, Fumihiro Akiyama1, Shiro Maeda5, Yozo Ohnishi4, Ryo Yamada6, Tatsuhiko Tsunoda7, Takashi Takei8, Kyoko Ito8, Kazuho Honda8, Keiko Uchida8, Ken Tsuchiya8, Wako Yumura8, Takashi Ujiie9, Yutaka Nagane10, Kosaku Nitta8, Satoru Miyano1, Ichiei Narita11, Fumitake Gejyo11, Hiroshi Nihei8, Tomoaki Fujioka2, Yusuke Nakamura12,13.   

Abstract

Immunoglobulin A nephropathy (IgAN) is a primary glomerulonephritis of common incidence world-wide whose etiology and pathogenesis remain unresolved, although genetic factors are assumed to be involved in the development and progression of this disease. To identify genetic variations that might confer susceptibility to IgAN, we performed a case-control association study involving 389 Japanese IgAN patients and 465 controls. Genome-wide analysis of approximately 80,000 single-nucleotide polymorphisms (SNPs) identified a significant association between IgAN and six SNPs located in the PIGR (polymeric immuoglobulin receptor) gene at chromosome 1q31-q41. One of them, PIGR-17, caused an amino-acid substitution from alanine to valine at codon 580 (chi(2)=13.05, P=0.0003, odds ratio [OR] =1.59, 95% confidence interval [95% CI] =1.24-2.05); the OR of minor homozygotes to others was 2.71 (95% CI=1.31-5.61). Another SNP, PIGR-2, could affect promoter activity (chi(2)=11.95, P=0.00055, OR=1.60, 95% CI=1.22-2.08); the OR of minor homozygotes to others was 2.08 (95% CI=0.94-4.60). Pairwise analyses demonstrated that all six SNPs were in almost complete linkage disequilibrium. Biopsy specimens from IgAN patients were positively stained by antibody against the secretory component of PIGR, but corresponding tissues from non-IgAN patients were not. Our results suggest that a gene associated with susceptibility to IgAN lies within or close to the PIGR gene locus on chromosome 1q in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740691     DOI: 10.1007/s10038-003-0027-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  24 in total

1.  A high-throughput SNP typing system for genome-wide association studies.

Authors:  Y Ohnishi; T Tanaka; K Ozaki; R Yamada; H Suzuki; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy.

Authors:  J W de Fijter; J W Eijgenraam; C A Braam; J Holmgren; M R Daha; L A van Es; A W van den Wall Bake
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

3.  Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.

Authors:  A Koyama; M Igarashi; M Kobayashi
Journal:  Am J Kidney Dis       Date:  1997-04       Impact factor: 8.860

4.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.

Authors:  E Lander; L Kruglyak
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

Review 5.  Immunogenetic aspects of primary IgA nephropathy.

Authors:  F P Schena
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

6.  Perturbation of mucosal immune defence mechanisms by bacterial IgA proteases.

Authors:  M Kilian; J Reinholdt; S B Mortensen; C H Sørensen
Journal:  Bull Eur Physiopathol Respir       Date:  1983 Mar-Apr

7.  Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA.

Authors:  S Shimada; M Kawaguchi-Miyashita; A Kushiro; T Sato; M Nanno; T Sako; Y Matsuoka; K Sudo; Y Tagawa; Y Iwakura; M Ohwaki
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 8.  Evidence for genetic factors in the development and progression of IgA nephropathy.

Authors:  S I Hsu; S B Ramirez; M P Winn; J V Bonventre; W F Owen
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

9.  IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.

Authors:  A G Gharavi; Y Yan; F Scolari; F P Schena; G M Frasca; G M Ghiggeri; K Cooper; A Amoroso; B F Viola; G Battini; G Caridi; C Canova; A Farhi; V Subramanian; C Nelson-Williams; S Woodford; B A Julian; R J Wyatt; R P Lifton
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

10.  Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA.

Authors:  A W van den Wall Bake; M R Daha; J Evers-Schouten; L A van Es
Journal:  Am J Kidney Dis       Date:  1988-11       Impact factor: 8.860

View more
  17 in total

Review 1.  Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Authors:  S Bournazos; J M Woof; S P Hart; I Dransfield
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

2.  Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy.

Authors:  Shigeru Ohtsubo; Aritoshi Iida; Kosaku Nitta; Toshihiro Tanaka; Ryo Yamada; Yozo Ohnishi; Shiro Maeda; Tatsuhiko Tsunoda; Takashi Takei; Wataru Obara; Fumihiro Akiyama; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Takashi Ujiie; Yutaka Nagane; Satoru Miyano; Yasushi Suzuki; Ichiei Narita; Fumitake Gejyo; Tomoaki Fujioka; Hiroshi Nihei; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-12-14       Impact factor: 3.172

3.  HLA has strongest association with IgA nephropathy in genome-wide analysis.

Authors:  John Feehally; Martin Farrall; Anne Boland; Daniel P Gale; Ivo Gut; Simon Heath; Ashish Kumar; John F Peden; Patrick H Maxwell; David L Morris; Sandosh Padmanabhan; Timothy J Vyse; Anna Zawadzka; Andrew J Rees; Mark Lathrop; Peter J Ratcliffe
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

4.  No association of monocyte chemoattractant protein-1 -2518 A/G polymorphism with the risk of primary glomerulonephritis in the Polish population.

Authors:  Magdalena Mostowska; Margarita Lianeri; Andrzej Oko; Adrianna Mostowska; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

5.  Reduced immunoglobulin A transcytosis associated with immunoglobulin A nephropathy and nasopharyngeal carcinoma.

Authors:  Tao Su; Steven J Chapin; David M Bryant; Annette M Shewan; Kitty Young; Keith E Mostov
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

Review 6.  IgA nephropathy enigma.

Authors:  Jiri Mestecky; Jan Novak; Zina Moldoveanu; Milan Raska
Journal:  Clin Immunol       Date:  2016-07-18       Impact factor: 3.969

7.  Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.

Authors:  J W Eijgenraam; B D Oortwijn; S W A Kamerling; J W de Fijter; A W L van den Wall Bake; M R Daha; C van Kooten
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 8.  Food fight! Parenteral nutrition, enteral stimulation and gut-derived mucosal immunity.

Authors:  Joshua L Hermsen; Yoshifumi Sano; Kenneth A Kudsk
Journal:  Langenbecks Arch Surg       Date:  2008-06-03       Impact factor: 3.445

9.  Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.

Authors:  Salma Ben-Salem; Joseph G Gleeson; Aisha M Al-Shamsi; Barira Islam; Jozef Hertecant; Bassam R Ali; Lihadh Al-Gazali
Journal:  Metab Brain Dis       Date:  2014-09-17       Impact factor: 3.584

10.  Development of a model of early-onset IgA nephropathy.

Authors:  Keiko Okazaki; Yusuke Suzuki; Mareki Otsuji; Hitoshi Suzuki; Masao Kihara; Tadahiro Kajiyama; Azusa Hashimoto; Hiroyuki Nishimura; Rhubell Brown; Stacy Hall; Jan Novak; Shozo Izui; Sachiko Hirose; Yasuhiko Tomino
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.